Physician profile
Hector Munoz
NPI 1740643931
$409.54
in general payments reported to CMS, 2019-2025
10 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.21 · 2023: $97.90 · 2024: $138 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $76.88 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $67.98 | 2023-2025 | Livalo, Seglentis, Zoryve |
| Novo Nordisk INC | $53.39 | 2023-2025 | |
| Nevro Corp. | $48.81 | 2024 | Senza |
| Hologic Sales and Service, LLC | $35.45 | 2024 | Aptima |
| Vanda Pharmaceuticals INC. | $34.75 | 2023 | Hetlioz |
| Organon LLC | $28.01 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.79 | 2025 | |
| Amgen INC. | $20.26 | 2025 | Otezla, Repatha |
| Phathom Pharmaceuticals, INC. | $19.22 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.